VIEW ISSUES The Lyme Times provides information about a wide variety of subjects related to Lyme and other tick-borne diseases LEADER IN LYME DISEASE ADVOCACY LymeTimes 2021 Spring LymeTimes Archives
Spring 2020

Table Of Contents
Disulfiram: A Breakthrough Drug for Lyme and Other Tick-Borne Diseases?

Disulfiram could be a game changer for the treatment of Lyme and Bartonella.

By Daniel A. Kinderlehrer, MD

What is disulfiram and why is it sparking excitement in the Lyme community?

The novel use of an older drug provides new hope for Lyme patients and underscores the need for further research. But caution is required.

By Kristina Bauer and
Cozette Moysa

Many Patients Find Disulfiram a “Game-Changing” Lyme Treatment

Whereas Dr. Daniel A. Kinderlehrer previously held reservations about calling disulfiram a breakthrough, he now says that it is definitively a breakthrough in the treatment of Lyme disease and babesiosis.

By Daniel A. Kinderlehrer, MD

Justin Bieber’s Lyme disease story lights up the internet

Bieber’s documentary series discusses the “scary symptoms” he endured throughout most of 2019 — until he was finally diagnosed with Lyme disease.

By Dorothy Kupcha Leland

FAIR Health’s Report Shows Lyme Insurance Claims Made a Huge Jump in the U.S.

A new report indicates that claim lines with the diagnosis of Lyme disease increased in the U.S. by 117 percent between 2007 and 2018.

By Dorothy Kupcha Leland

A patient interviews Dr. Kinderlehrer about disulfiram for Lyme disease

Many Lyme patients report feeling greatly improved after disulfiram therapy.

By Kristina Bauer

Twenty-Four Things You Should Know about Being in Lyme Remission

Savannah Marcum shares several tips she has learned throughout her journey of remission.

By Savannah Marcum

Minnesota Medical Board Ties the Hands of Lyme-Treating Doctors

Doctors who prescribe long-term antibiotics for Lyme disease risk losing their licenses.

By Mary Beth Pfeiffer

Lyme Advocates Push for Funding and Accountability — and Congress Agrees

Advocates for patients with Lyme and other tick-borne diseases made some headway on Capitol Hill in 2019.

By Bruce Fries

Most Popular Articles


Subscribe to our mailing list and get Lyme disease news updates to your email inbox.

We respect your privacy and take protecting it seriously.